Global Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Summary

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or wild pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

According to APO Research, The global Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Vaccine include AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK and Hulan Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Vaccine, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Vaccine, also provides the revenue of main regions and countries. Of the upcoming market potential for Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccine revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Vaccine revenue, projected growth trends, production technology, application and end-user industry.

Vaccine segment by Company

AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Vaccine segment by Type

Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
Vaccine segment by Application

For Adult
For Child
Vaccine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia

Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccine industry.
Chapter 3: Detailed analysis of Vaccine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccinerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Varicella Vaccine
1.2.3 Influenza Vaccine
1.2.4 Polio Vaccine
1.2.5 Hepatitis A Vaccine
1.2.6 Rabies Vaccine
1.2.7 BCG Vaccine
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Others
1.3 Market Analysis by Application
1.3.1 Global Vaccine Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 For Adult
1.3.3 For Child
1.4 Global Market Growth Prospects
1.5 Global Vaccine Growth Trends by Region
1.5.1 Global Vaccine Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Vaccine Market Size by Region (2019-2024)
1.5.3 Vaccine Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Vaccine Market Dynamics
2.1 Vaccine Industry Trends
2.2 Vaccine Industry Drivers
2.3 Vaccine Industry Opportunities and Challenges
2.4 Vaccine Industry Restraints
3 Competitive Landscape by Company
3.1 Global Vaccine Revenue by Company (2019-2024)
3.2 Global Vaccine Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Vaccine Key Company Head office and Area Served
3.4 Global Vaccine Company, Product Type & Application
3.5 Global Vaccine Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Vaccine Market CR5 and HHI
3.6.2 Global Top 5 and 10 Vaccine Players Market Share by Revenue in 2023
3.6.3 2023 Vaccine Tier 1, Tier 2, and Tier 3
4 Vaccine Market by Type
4.1 Global Vaccine Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Vaccine Market Size by Type (2019-2030)
4.3 Global Vaccine Market Size Share by Type (2019-2030)
5 Vaccine Market by Application
5.1 Global Vaccine Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Vaccine Market Size by Application (2019-2030)
5.3 Global Vaccine Market Size Share by Application (2019-2030)
6 Company Profiles
6.1 AstraZeneca
6.1.1 AstraZeneca Comapny Information
6.1.2 AstraZeneca Business Overview
6.1.3 AstraZeneca Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 AstraZeneca Vaccine Product Portfolio
6.1.5 AstraZeneca Recent Developments
6.2 BioNTech
6.2.1 BioNTech Comapny Information
6.2.2 BioNTech Business Overview
6.2.3 BioNTech Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 BioNTech Vaccine Product Portfolio
6.2.5 BioNTech Recent Developments
6.3 Boehringer-Ingelheim
6.3.1 Boehringer-Ingelheim Comapny Information
6.3.2 Boehringer-Ingelheim Business Overview
6.3.3 Boehringer-Ingelheim Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 Boehringer-Ingelheim Vaccine Product Portfolio
6.3.5 Boehringer-Ingelheim Recent Developments
6.4 CCBIO
6.4.1 CCBIO Comapny Information
6.4.2 CCBIO Business Overview
6.4.3 CCBIO Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 CCBIO Vaccine Product Portfolio
6.4.5 CCBIO Recent Developments
6.5 CSL
6.5.1 CSL Comapny Information
6.5.2 CSL Business Overview
6.5.3 CSL Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 CSL Vaccine Product Portfolio
6.5.5 CSL Recent Developments
6.6 CureVac
6.6.1 CureVac Comapny Information
6.6.2 CureVac Business Overview
6.6.3 CureVac Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 CureVac Vaccine Product Portfolio
6.6.5 CureVac Recent Developments
6.7 Elanco
6.7.1 Elanco Comapny Information
6.7.2 Elanco Business Overview
6.7.3 Elanco Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Elanco Vaccine Product Portfolio
6.7.5 Elanco Recent Developments
6.8 GSK
6.8.1 GSK Comapny Information
6.8.2 GSK Business Overview
6.8.3 GSK Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 GSK Vaccine Product Portfolio
6.8.5 GSK Recent Developments
6.9 Hulan Bio
6.9.1 Hulan Bio Comapny Information
6.9.2 Hulan Bio Business Overview
6.9.3 Hulan Bio Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Hulan Bio Vaccine Product Portfolio
6.9.5 Hulan Bio Recent Developments
6.10 Indian Immunologicals
6.10.1 Indian Immunologicals Comapny Information
6.10.2 Indian Immunologicals Business Overview
6.10.3 Indian Immunologicals Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.10.4 Indian Immunologicals Vaccine Product Portfolio
6.10.5 Indian Immunologicals Recent Developments
6.11 Merck
6.11.1 Merck Comapny Information
6.11.2 Merck Business Overview
6.11.3 Merck Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.11.4 Merck Vaccine Product Portfolio
6.11.5 Merck Recent Developments
6.12 Minhai Biotechnology
6.12.1 Minhai Biotechnology Comapny Information
6.12.2 Minhai Biotechnology Business Overview
6.12.3 Minhai Biotechnology Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.12.4 Minhai Biotechnology Vaccine Product Portfolio
6.12.5 Minhai Biotechnology Recent Developments
6.13 Mitsubishi Tanabe Pharma
6.13.1 Mitsubishi Tanabe Pharma Comapny Information
6.13.2 Mitsubishi Tanabe Pharma Business Overview
6.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.13.4 Mitsubishi Tanabe Pharma Vaccine Product Portfolio
6.13.5 Mitsubishi Tanabe Pharma Recent Developments
6.14 Moderna Therapeutics
6.14.1 Moderna Therapeutics Comapny Information
6.14.2 Moderna Therapeutics Business Overview
6.14.3 Moderna Therapeutics Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.14.4 Moderna Therapeutics Vaccine Product Portfolio
6.14.5 Moderna Therapeutics Recent Developments
6.15 Mylan
6.15.1 Mylan Comapny Information
6.15.2 Mylan Business Overview
6.15.3 Mylan Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.15.4 Mylan Vaccine Product Portfolio
6.15.5 Mylan Recent Developments
6.16 Plumbline Life Sciences
6.16.1 Plumbline Life Sciences Comapny Information
6.16.2 Plumbline Life Sciences Business Overview
6.16.3 Plumbline Life Sciences Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.16.4 Plumbline Life Sciences Vaccine Product Portfolio
6.16.5 Plumbline Life Sciences Recent Developments
6.17 Sanofi
6.17.1 Sanofi Comapny Information
6.17.2 Sanofi Business Overview
6.17.3 Sanofi Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.17.4 Sanofi Vaccine Product Portfolio
6.17.5 Sanofi Recent Developments
6.18 Translate Bio
6.18.1 Translate Bio Comapny Information
6.18.2 Translate Bio Business Overview
6.18.3 Translate Bio Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.18.4 Translate Bio Vaccine Product Portfolio
6.18.5 Translate Bio Recent Developments
6.19 Walvax Biotechnology
6.19.1 Walvax Biotechnology Comapny Information
6.19.2 Walvax Biotechnology Business Overview
6.19.3 Walvax Biotechnology Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.19.4 Walvax Biotechnology Vaccine Product Portfolio
6.19.5 Walvax Biotechnology Recent Developments
6.20 Wuhan Institute of Biological Products
6.20.1 Wuhan Institute of Biological Products Comapny Information
6.20.2 Wuhan Institute of Biological Products Business Overview
6.20.3 Wuhan Institute of Biological Products Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.20.4 Wuhan Institute of Biological Products Vaccine Product Portfolio
6.20.5 Wuhan Institute of Biological Products Recent Developments
6.21 Zoties
6.21.1 Zoties Comapny Information
6.21.2 Zoties Business Overview
6.21.3 Zoties Vaccine Revenue and Gross Margin (US$ Million) & (2019-2024)
6.21.4 Zoties Vaccine Product Portfolio
6.21.5 Zoties Recent Developments
7 North America
7.1 North America Vaccine Market Size (2019-2030)
7.2 North America Vaccine Market Size by Type
7.2.1 North America Vaccine Market Size by Type (2019-2024)
7.2.2 North America Vaccine Market Size by Type (2025-2030)
7.2.3 North America Vaccine Market Share by Type (2019-2030)
7.3 North America Vaccine Market Size by Application
7.3.1 North America Vaccine Market Size by Application (2019-2024)
7.3.2 North America Vaccine Market Size by Application (2025-2030)
7.3.3 North America Vaccine Market Share by Application (2019-2030)
7.4 North America Vaccine Market Size by Country
7.4.1 North America Vaccine Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Vaccine Market Size by Country (2019-2024)
7.4.3 North America Vaccine Market Size by Country (2025-2030)
7.4.4 North America Vaccine Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 Europe
8.1 Europe Vaccine Market Size (2019-2030)
8.2 Europe Vaccine Market Size by Type
8.2.1 Europe Vaccine Market Size by Type (2019-2024)
8.2.2 Europe Vaccine Market Size by Type (2025-2030)
8.2.3 Europe Vaccine Market Share by Type (2019-2030)
8.3 Europe Vaccine Market Size by Application
8.3.1 Europe Vaccine Market Size by Application (2019-2024)
8.3.2 Europe Vaccine Market Size by Application (2025-2030)
8.3.3 Europe Vaccine Market Share by Application (2019-2030)
8.4 Europe Vaccine Market Size by Country
8.4.1 Europe Vaccine Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Vaccine Market Size by Country (2019-2024)
8.4.3 Europe Vaccine Market Size by Country (2025-2030)
8.4.4 Europe Vaccine Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Vaccine Market Size (2019-2030)
9.2 China Vaccine Market Size by Type
9.2.1 China Vaccine Market Size by Type (2019-2024)
9.2.2 China Vaccine Market Size by Type (2025-2030)
9.2.3 China Vaccine Market Share by Type (2019-2030)
9.3 China Vaccine Market Size by Application
9.3.1 China Vaccine Market Size by Application (2019-2024)
9.3.2 China Vaccine Market Size by Application (2025-2030)
9.3.3 China Vaccine Market Share by Application (2019-2030)
10 Asia
10.1 Asia Vaccine Market Size (2019-2030)
10.2 Asia Vaccine Market Size by Type
10.2.1 Asia Vaccine Market Size by Type (2019-2024)
10.2.2 Asia Vaccine Market Size by Type (2025-2030)
10.2.3 Asia Vaccine Market Share by Type (2019-2030)
10.3 Asia Vaccine Market Size by Application
10.3.1 Asia Vaccine Market Size by Application (2019-2024)
10.3.2 Asia Vaccine Market Size by Application (2025-2030)
10.3.3 Asia Vaccine Market Share by Application (2019-2030)
10.4 Asia Vaccine Market Size by Country
10.4.1 Asia Vaccine Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Vaccine Market Size by Country (2019-2024)
10.4.3 Asia Vaccine Market Size by Country (2025-2030)
10.4.4 Asia Vaccine Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Vaccine Market Size (2019-2030)
11.2 MEALA Vaccine Market Size by Type
11.2.1 MEALA Vaccine Market Size by Type (2019-2024)
11.2.2 MEALA Vaccine Market Size by Type (2025-2030)
11.2.3 MEALA Vaccine Market Share by Type (2019-2030)
11.3 MEALA Vaccine Market Size by Application
11.3.1 MEALA Vaccine Market Size by Application (2019-2024)
11.3.2 MEALA Vaccine Market Size by Application (2025-2030)
11.3.3 MEALA Vaccine Market Share by Application (2019-2030)
11.4 MEALA Vaccine Market Size by Country
11.4.1 MEALA Vaccine Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Vaccine Market Size by Country (2019-2024)
11.4.3 MEALA Vaccine Market Size by Country (2025-2030)
11.4.4 MEALA Vaccine Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings